Integrated Diagnostics Holdings PLC — Proxy Solicitation & Information Statement 2026

Apr 17, 2026

THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION.

If you are in any doubt as to the action you should take, you are recommended to seek your own personal financial advice immediately from your stockbroker, solicitor, accountant or other independent financial adviser duly authorised under the Financial Services and Markets Act 2000 if you are resident in the United Kingdom or, if not, from another appropriate authorised independent financial adviser.

If you have sold or otherwise transferred all of your Shares, please forward this document at once to the purchaser or transferee or to the stockbroker, bank or other agent through whom the sale or transfer was effected, for delivery to the purchaser or transferee. If you have sold or otherwise transferred only part of your holding of Shares, you should retain these documents.

---

INTEGRATED DIAGNOSTICS HOLDINGS PLC

CHAIRMAN'S LETTER AND NOTICE OF ANNUAL GENERAL MEETING 2026

Shareholders should read the whole of this document.

Notice of the Annual General Meeting ("AGM") of Integrated Diagnostics Holdings plc (the "Company") to be held at Strand Hanson LTD, 26 Mount Row, Mayfair, London W1K 3SQ on 19 May 2026 at 3.00 pm British Summer Time ("BST") is set out in this document.

Whether or not you propose to attend the Annual General Meeting, please complete your proxy electronically via the Investor Centre app or web browser at https://uk.investorcentre.mpms.mufg.com/ by 3.00 pm BST on 15 May 2026 (or, in the case of an adjournment, not later than 48 hours, excluding non-working days, before the time fixed for the holding of the adjourned meeting). Alternatively, you can vote via the CREST or Proxymity, please refer to pages 6 and 7 for further instructions.

---

INTEGRATED DIAGNOSTICS HOLDINGS PLC

LETTER FROM THE CHAIRMAN

Registered Office Address:
IFC 5, St Helier, Jersey, JE1 1ST, Channel Islands

Dear Shareholder,

I am pleased to invite you to the Annual General Meeting ("AGM") of Integrated Diagnostics Holdings Plc (the "Company") which will be held at Strand Hanson LTD, 26 Mount Row, Mayfair, London W1K 3SQ on 19 May 2026 at 3.00 pm BST.

BUSINESS OF THE AGM

The business to be conducted at the AGM is set out in pages 3 to 10 of this document with explanatory notes concerning each of the resolutions ("Notice"). A copy of this Notice and the Company's annual report for the year ended 31 December 2025 can be viewed on our website at www.idhcorp.com.

VOTING & QUESTIONS

The Board unanimously recommends that you vote in favour of all the Resolutions, as the Directors intend to do in respect of their own beneficial shareholdings where applicable.

The Board remains keen to encourage engagement with Shareholders. To that end, the Directors would like to invite questions from Shareholders in advance of and during the AGM. Should Shareholders wish to submit questions to the Board prior to the deadline for proxy voting they can do so, and these will be responded to on an individual basis. In addition, the Board will offer shareholders the opportunity to dial into the AGM, at which time they can also submit questions to the Board.

Shareholders wishing to access the dial-in facility or submit questions are asked to email Tarek Yehia at tarek.yehia@idhcorp.com by close of business on Wednesday, 13 May 2026.

If you are unable to attend the AGM but would like to vote on the Resolutions, I kindly request for you to submit your proxy vote electronically via the Investor Centre app or web browser at https://uk.investorcentre.mpms.mufg.com/ or in accordance with the instructions set out in note 2 on pages 6 to 8. All proxy instructions must be received no later than 3.00 pm BST on 15 May 2026.

Yours faithfully,

LORD ANTHONY ST JOHN, CHAIRMAN

Dated: 16 April 2026

2

---

INTEGRATED DIAGNOSTICS HOLDINGS PLC
(Incorporated in Jersey with registered number 117257)

NOTICE OF ANNUAL GENERAL MEETING

Notice is hereby given that the Annual General Meeting of Integrated Diagnostics Holdings Plc (the "Company") will be held at Strand Hanson LTD, 26 Mount Row, Mayfair, London W1K 3SQ on 19 May 2026 at 3.00pm BST.

Resolutions 1 to 14 will be proposed as ordinary resolutions; this means that for each of those ordinary resolutions to be passed, more than half of the votes cast (in person or by proxy) must be in favour. Resolutions 15 to 16 will be proposed as special resolutions; this means that for each of those special resolutions to be passed, at least three-quarters of the votes cast (in person or by proxy) must be in favour.

ORDINARY RESOLUTIONS

1. To receive the Company's Audited Financial Statements, together with the reports of the Directors and the Auditor for the year ended 31 December 2025.
2. To re-elect Lord Anthony Tudor St John as a Director of the Company.
3. To re-elect Dr. Hend El-Sherbini as a Director of the Company.
4. To re-elect Sherif El Zeiny as a Director of the Company.
5. To re-elect Richard Henry Phillips as a Director of the Company.
6. To re-elect Dan Johan Wilmar Olsson as a Director of the Company.
7. To re-elect Hussein Hassan Choucri as a Director of the Company.
8. To re-elect Yvonne Stillhart as a Director of the Company.
9. To re-appoint PricewaterhouseCoopers LLP (the "Auditor") as auditor of the Company to hold office from the conclusion of this meeting until the conclusion of the next annual general meeting at which annual report and accounts are laid before the Company.
10. To authorise the Audit Committee to determine the Auditor's remuneration.
11. To declare a final dividend of USD 0.0085 per Share in respect of the year ended 31 December 2025 to be paid on 22 June 2026 to the holders of Shares on the register of members as at the close of business on 29 May 2026, with an ex-dividend date of 28 May 2026.
12. THAT, in substitution for all existing and unexercised authorities and powers, the directors of the Company be and they are hereby generally and unconditionally authorised for the purpose of article 12 of the Articles of Association to exercise all or any of the powers of the Company to issue and allot or agree to issue and allot Equity Securities of the Company or to grant rights to subscribe for, or to convert any security into, Equity Securities of the Company up to 116,265,254 ordinary US$0.25 shares, being approximately 20 per cent of the current issued share capital of the Company (the Authorised Allotment Amount), to such persons at such times and generally on such terms and conditions as the directors may determine (subject always to the Articles of Association).

PROVIDED THAT, this authority shall, unless previously renewed, varied or revoked by the Company in general meeting, expire at the conclusion of the next annual general meeting save that the directors of the Company may issue and allot or agree to issue and allot Equity Securities, notwithstanding that this authority has expired, if they are allotted in pursuance of an offer or agreement made by the Company before this authority expires, which would or might require Equity Securities to be allotted after this authority expires.

1. THAT pursuant to Article 58A (1)(b) of the Companies (Jersey) Law 1991, the holding by the Company of the Equity Securities purchased to the authority conferred by Resolution 16 as

---

treasury shares in accordance with the provisions of the Companies (Jersey) Law 1991 be approved.

1. THAT the execution and delivery by the Company of any documents that are necessary or expedient in connection with the Company holding the Equity Securities purchased pursuant to the authority conferred by Resolution 12 as treasury shares be approved.

SPECIAL RESOLUTIONS

To consider and, if thought fit, pass the following resolutions as Special Resolutions:

1. THAT, subject to and conditional upon the passing of the Resolution numbered 12 in the notice convening the meeting at which this resolution was proposed and in substitution for all existing and unexercised authorities and powers, the directors of the Company be and are hereby empowered generally and unconditionally pursuant to article 12.4 of the Articles of Association to allot Equity Securities (whether directly, or by way of options, warrants, convertible instruments or other grant of rights for Equity Securities convertible upon exercise of such options, warrants, convertible instruments or other grant of rights) pursuant to the authority conferred upon them by Resolution 12, such that article 13.1 of the Articles of Association shall not apply to the allotment, provided that this authority and power shall be limited to:

(i) the allotment of Equity Securities in connection with a rights issue or similar offer in favour of ordinary shareholders where the Equity Securities respectively attributable to the interest of all ordinary shareholders are proportionate (as nearly as may be) to the respective numbers of ordinary shares held by them subject only to such exclusions or other arrangements as the directors of the Company may consider appropriate to deal with fractional entitlements, treasury shares, record dates or legal and practical difficulties under the laws of, or the requirements of any recognised regulatory body of, any territory;

(ii) the allotment (otherwise than pursuant to sub-paragraph (i) above) of up to 29,066,313 ordinary shares of US$0.25, representing approximately 5 per cent of the current issued share capital of the Company (the Non Pre-emptive Amount);

and this authority shall, unless previously renewed, varied or revoked by the Company in general meeting, expire at the conclusion of the next annual general meeting save that the directors of the Company may allot Equity Securities or rights to subscribe for or convert securities into Equity Securities notwithstanding that this authority has expired, if they are allotted in pursuance of an offer or agreement made by the Company before this authority expires, which would or might require Equity Securities to be allotted after this authority expires.

1. THAT the Company is hereby generally and unconditionally authorised pursuant to Article 57 of the Companies (Jersey) Law 1991 to make market purchases of Equity Securities in the capital of the Company on such terms and in such manner as the Directors shall determine provided that:

(i) the maximum number of Equity Securities authorised to be purchased is 58,132,627, representing up to 10% of the sum of the issued ordinary share capital of the Company as at the date of this Circular;

(ii) the minimum price which may be paid for each Equity Security is US$0.25;

(iii) the maximum price (exclusive of expenses) which may be paid for each Equity Security is, in respect of a share contracted to be purchased on any day, an amount equal to the higher of (i) 105% of the average of the closing middle market quotations for the Equity Securities taken from the Daily Official List of the London Stock Exchange for the five business days immediately preceding the day on which that Equity Security is to be purchased; and (ii) the higher of the last independent trade and the highest current independent bid for the Equity Security on the London Stock Exchange at the relevant time.

and this authority will (unless previously renewed, varied or revoked by the Company in general meeting) expire at the conclusion of the next annual general meeting of the Company held after the date on which this resolution is passed or, if earlier, at close of business on the day falling 15 months after that date, save that the Company may make a contract to purchase Equity

4

---

Securities under this authority before this authority expires which will or may be executed wholly or partly after its expiration.

By order of the Board of Directors of Integrated Diagnostics Holdings Plc

LORD ANTHONY ST JOHN, CHAIRMAN
Dated: 16 April 2026

Registered Office Address:
IFC 5, St Helier, Jersey, JE1 1ST, Channel Islands

5

---

EXPLANATORY NOTES TO THE NOTICE OF ANNUAL GENERAL MEETING

1. DEFINITIONS

"Articles of Association" the Articles of Association of the Company

"Authorised Allotment Amount" the nominal amount of Equity Securities the Board are authorised to allot under Article 12 of the Articles of Association

"Board" or "Directors" the directors of the Company and "Director" shall mean any of them

"Non Pre-emptive Amount" the nominal amount of Equity Securities the Board are authorised to allot under Article 12.4 of the Articles of Association on a non-pre-emptive basis

"Register of Members" the register of members of the Company

"Equity Securities" ordinary shares in the company, or rights to subscribe for, or to convert securities into, ordinary shares in the company

"Resolutions" the resolutions set out in the Notice and "Resolution" shall mean any of them

"Shareholders" the holders of the Shares

"Shares" ordinary shares of US$0.25 in the capital of the Company

2. PROXY INFORMATION

2.1. Only Shareholders, or their duly appointed representatives, are entitled to attend and vote at the Annual General Meeting. A Shareholder so entitled may appoint one or more proxies (whether they are Shareholders or not) to attend and, on a poll, to vote in place of the Shareholder.

2.2. To appoint a proxy, the Form of Proxy and any power of attorney or other authority under which it is executed (or a duly certified copy of any such power or authority), must be either:

• submitted electronically via the Investor Centre app or web browser at https://uk.investorcentre.mpms.mufg.com/, by no later than the deadline set out below. In order to appoint a proxy using the Investor Centre, members will need to log into their Investor Centre account or register if they have not previously done so. To register, members will need to identify themselves with their Investor Code which is detailed on their share certificate or available from our Registrar, MUFG Corporate Markets.

Investor Centre is a free app for smartphone and tablet provided by MUFG Corporate Markets (the company's registrar). It allows you to securely manage and monitor your shareholdings in real time, take part in online voting, keep your details up to date, access a range of information including payment history and much more. The app is available to download on both the Apple App Store and Google Play, or by scanning the relevant QR code below;

Apple App Store

GooglePlay

• Or if you are an institutional investor you may also be able to appoint a proxy electronically via the Proxymity platform, a process which has been agreed by the Company and approved by the Registrar. For further information regarding Proxymity, please go to www.proxymity.io. Your proxy must be lodged by 3:00pm BST on 15 May 2026 in order to be considered valid or, if the meeting is adjourned, by the time which is 48 hours before the time of the adjourned meeting. Before you can appoint a proxy via this process you will need to have agreed to Proxymity's associated terms and conditions.

---

It is important that you read these carefully as you will be bound by them and they will govern the electronic appointment of your proxy. An electronic proxy appointment via the Proxymity platform may be revoked completely by sending an authenticated message via the platform instructing the removal of your proxy vote.

• Lodged using the CREST Proxy Voting Service in accordance with the procedure set out below; or
• by requesting a hard copy form of proxy directly from the registrars, MUFG Corporate Markets, by email at shareholderenquiries@cm.mpms.mufg.com or on Tel: 0371 664 0300. Calls are charged at the standard geographic rate and will vary by provider. Calls outside the United Kingdom will be charged at the applicable international rate. We are open between 09:00 – 17:30 BST, Monday to Friday excluding public holidays in England and Wales.

in each case so as to be received no later than 3.00pm BST on 15 May 2026.

2.3. The form of proxy and the power of attorney or other authority, if any, under which it is executed, or a copy of it certified by a notary, shall be delivered to PXS 1, MUFG Corporate Markets, Central Square, 29 Wellington Street, Leeds, LS1 4DL no later than 3.00pm BST on 15 May 2026, being 48 hours, excluding non-working days before the time appointed for holding the Annual General Meeting or adjourned meeting or the taking of a poll (as the case may be) at which the person named in such form of proxy.

2.4. CREST members who wish to appoint a proxy or proxies through the CREST electronic proxy appointment service may do so for the Annual General Meeting to be held on 19 May 2026 at 3.00pm BST and any adjournment(s) thereof by using the procedures described in the CREST Manual. CREST personal members or other CREST sponsored members, and those CREST members who have appointed a voting service provider should refer to their CREST sponsors or voting service provider(s), who will be able to take the appropriate action on their behalf.

2.5. In order for a proxy appointment or instruction made by means of CREST to be valid, the appropriate CREST message (a "CREST Proxy Instruction") must be properly authenticated in accordance with Euroclear UK & International Limited's specifications and must contain the information required for such instructions, as described in the CREST Manual. The message must be transmitted so as to be received by the Company's agent, MUFG Corporate Markets (CREST Participant ID: RA10), no later than 3.00pm BST on 15 May 2026 being 48 hours, excluding non-working days, before the time appointed for the meeting. For this purpose, the time of receipt will be taken to be the time (as determined by the time stamp applied to the message by the CREST Application Host) from which the Company's agent is able to retrieve the message by enquiry to CREST in the manner prescribed by CREST.

2.6. CREST members and, where applicable, their CREST sponsor or voting service provider should note that Euroclear UK & International Limited does not make available special procedures in CREST for any particular messages. Normal system timings and limitations will therefore apply in relation to the input of CREST Proxy Instructions. It is the responsibility of the CREST member concerned to take (or, if the CREST member is a CREST personal member or sponsored member or has appointed a voting service provider, to procure that his CREST sponsor or voting service provider takes) such action as shall be necessary to ensure that a message is transmitted by means of the CREST system by any particular time. In this connection, CREST members and, where applicable, their CREST sponsor or voting service provider are referred in particular to those sections of the CREST Manual concerning practical limitations of the CREST system and timings.

2.7. The Company may treat as invalid a CREST Proxy Instruction in the circumstances set out in Regulation 35(5)(a) of the Uncertificated Securities Regulations 2001.

2.8. Unless otherwise indicated on the Form of Proxy, CREST, Proxymity or any other electronic voting instruction, the proxy will vote as they think fit or, at their discretion, withhold from voting.

2.9. Delivery of a form of proxy shall not preclude a Shareholder from attending and voting in person at the Annual General Meeting or poll concerned and, in such event, the form of proxy shall be deemed to be revoked.

2.10. Any corporation which is a Shareholder may, by resolution of its directors or other governing body or in accordance with its governing law or constitutional documents, authorise such person

7

---

as it thinks fit to act as its representative at the Annual General Meeting, and the persons so authorised shall be entitled to exercise the same powers on behalf of the corporation which they represent as that corporation could exercise if it were a natural person who is a Shareholder. A Director, the Secretary or other person authorised for the purpose by the Secretary may require a representative to produce a certified copy of the resolution of authorisation before permitting him to exercise his powers.

3. CLOSURE OF REGISTER

3.1. The Company specifies that only those Shareholders registered in the Register of Members of the Company as at close of business on 15 May 2026 (being 48 hours, excluding non-working days, before the AGM in accordance with Article 40 of the Companies (Uncertificated Securities) (Jersey) Order 1999) are entitled to attend or vote at the Annual General Meeting in respect to the number of Shares registered in their name at that time.

3.2. Changes to entries on the Register of Members after that time shall be disregarded when determining the rights of any person to attend or vote in the Annual General Meeting.

4. COMPANY'S SHARE CAPITAL

4.1. As at 15 April 2026 (being the last practicable date prior to publication of this document), the Company's issued share capital comprised 581,326,272 Shares. Each Share carries the right to one vote at a general meeting of the Company and therefore the total number of voting rights in the Company as at 15 April 2026 is 581,326,272. As at the date of this document, the Company does not hold any Shares in treasury.

5. VOTING BY POLL

5.1 Article 88 of the Articles of Association provides that at any general meeting, a resolution put to the vote of the meeting shall be decided on a show of hands unless, before or on the declaration of the result of the show of hands, a poll is duly demanded. Subject to the provisions of the Companies (Jersey) Law 1991, a poll may be demanded:

(i) by the Chairman; or
(ii) (except on the election of the chairman of the meeting or on a question of adjournment) by not less than 3 Shareholders present in person or by proxy and entitled to vote; or
(iii) by a Shareholder or Shareholders present in person or by proxy and representing not less than 10% of the total voting rights of all the Shareholders having the right to vote on the resolution; or
(iv) any Shareholder or Shareholders present in person or by proxy holding shares conferring a right to vote on the resolution, being shares on which an aggregate sum has been paid up equal to not less than 10% of the total sum paid up on all the shares conferring that right.

The appointment of a proxy to vote on a matter at a meeting authorises the proxy to demand, or join in demanding, a poll on that matter. In applying the provisions of this Article, a demand by a proxy counts (a) for the purposes of paragraph (ii) above, as a demand by the shareholder, (b) for the purposes of paragraph (iii) above, as a demand by a shareholder representing the voting rights that the proxy is authorised to exercise, and (c) for the purposes of paragraph (iv) above, as a demand by a shareholder holding the shares to which those rights are attached.

Article 89 of the Articles of Association further provides that unless a poll is so demanded (and the demand is not duly withdrawn), a declaration by the Chairman that a resolution has been carried or carried by a particular majority, or lost, or not carried by a particular majority and an entry to that effect in the minutes of the meeting shall be conclusive evidence of the fact without proof of the number or proportion of the votes recorded in favour of or against such resolution.

Article 90 of the Articles of Association provides that the demand for a poll may, before the poll is taken, be withdrawn but only with the consent of the Chairman and a demand so withdrawn shall not be taken to have invalidated the result on a show of hands declared before the demand was made. If a poll is demanded before the declaration of the result of a show of hands and the demand is duly withdrawn, the meeting shall continue as if the demand had not been

8

---

made. If the demand for a poll is withdrawn, the Chairman or any other member entitled may demand a poll.

1. Article 78 of the Company's Articles of Association permits the right of a member to participate in the business of any general meeting shall include, without limitation, the right to speak, vote on a show of hands, vote on a poll, be represented by a proxy and have access to all documents which are required by the Companies (Jersey) Law 1991 – or these Articles to be made available at the meeting.

2. Article 72 of the Company's Articles of Association provides that, where so requested in the manner set out in section 527(4) of the United Kingdom's Companies Act 2006 by holders representing at least five per cent of the total voting rights of all the holders who have a right to vote at the general meeting at which the Company's annual accounts are laid, or by at least 100 holders who have such right to vote and hold shares in the Company on which there has been paid up an average sum, per member, of at least £100, the Company shall publish on its website a statement setting out any matter relating to the audit of the Company's accounts or any circumstances connected with an auditor of the Company ceasing to hold office, and the Company shall comply with all the obligations relating to the publication of such statement contained in the provisions of sections 527 to 529 (other than section 527(5) and excluding the reference to "See also section 153 (exercise of rights where shares are held on behalf of others)" in section 527(2)) of the United Kingdom's Companies Act 2006 as if it were a company incorporated in the United Kingdom to which such provisions apply, provided always that the Company shall not be required to comply with the obligation set out in section 527(1) of the United Kingdom's Companies Act 2006 where the Board believes in good faith that the rights conferred by this article are being abused.

3. The notes below give further information in relation to the Resolutions to be considered at the AGM to be held on 19 May 2026.

Resolution 1 – Annual Report and Accounts

The Directors are required to present to the Annual General Meeting the audited accounts and the Directors' and Auditors' reports for the financial year ended 31 December 2025.

Resolutions 2 to 8 – Re-election of Directors

As at the date of the Notice, the Directors are:

1. Lord Anthony Tudor St John (Non-Executive Chairman)
2. Dr. Hend El-Sherbini (Chief Executive Officer)
3. Sherif El Zeiny (Group Chief Financial Officer)
4. Richard Henry Phillips (Non-Executive Director)
5. Dan Johan Wilmar Olsson (Non-Executive Director)
6. Hussein Hassan Choucri (Non-Executive Director)
7. Yvonne Stillhart (Non-Executive Director)

In accordance with the UK Corporate Governance Code and the Company's Articles of Association, all of the directors of the Company will be standing for re-election at the AGM. In accordance with the UK Listing Rules and the Articles, there will be an ordinary resolution for the re-election of all the directors. Their biological details are set out on pages 106 to 109 of the Annual Accounts for the year to 31 December 2025.

Resolutions 9 and 10 – Auditors' re-election and remuneration

Resolution 9 proposes the re-appointment of PwC LLP as auditor of the Company to hold office until the conclusion of the next general meeting at which accounts are laid before the Company.

Resolution 10 authorises the audit committee (for and on behalf of the Board) to agree the remuneration of the auditors.

---

10

Resolution 11 - Declaration of a final dividend

The amount of the final dividend recommended by the Directors is USD 0.0085 pence per ordinary share to be paid on 22 June 2026 to the shareholders on the register at the close of business on 29 May 2026. Final dividends must be approved by shareholders but must not exceed the amount recommended by the Directors.

Resolution 12 – Allotment of Relevant Securities

The Directors may only allot Equity Securities in the Company if they have been authorised to do so by Shareholders.

The authority imposed by Resolution 12 will be limited to 116,265,254 Equity Securities representing approximately 20 per cent of the Company's issued ordinary share capital as at 15 April 2026 (being the latest practicable date prior to the publication of this document). If given, this authority will expire at the conclusion of the Company's next AGM. The Directors have no immediate plans to use this authority.

Resolution 13 – Treasury Shares

The Company may hold in treasury any of its own Shares that it purchases pursuant to the authority conferred by Resolution 16, subject to the resolution being passed. This would give the Company the ability to re-issue treasury shares quickly and cost effectively and would provide the Company with greater flexibility in the management of its capital base.

Resolution 14 – Ancillary documents- Treasury shares

Resolution 14 will enable the Company to execute all such documents as necessary to hold the Shares it purchases pursuant to the authority conferred by Resolution 13 as treasury shares.

Resolution 15 – Disapplication of pre-emption rights

If the Directors wish to allot new shares or other equity securities for cash or sell treasury shares for cash, they must first offer such shares or securities to Shareholders in proportion to their existing holdings. These statutory pre-emption rights may be dis-applied by Shareholders. Resolution 15, which will be proposed as a special resolution will enable the Directors to allot for cash up to a maximum of 29,066,313 Equity Securities, representing approximately 5 per cent of the Company's issued ordinary share capital as at 15 April 2026 (being the latest practicable date prior to the publication of this document) either in connection with a rights issue or other pro rata offer or otherwise as if pre-emption rights did not apply to such allotment. The power will expire at the conclusion of the Company's next AGM.

Resolution 16 – Repurchase of Equity Securities

Resolution 16, which will be proposed as a special resolution, will authorise the Company to make market purchases of up to 58,132,627 Shares in the capital of the Company (being approximately 10% of the Company's current issued share capital) at prices not less than the nominal value of an ordinary share and not exceeding 105% of the average of the middle market quotations for the five business days before each purchase (exclusive of expenses). The authority will expire on the date falling 15 months after the earlier of the date of the passing of the resolution and the conclusion of the annual general meeting to approve the Report and Accounts for the year ending 31 December 2026. Your Directors have no current intention to make such purchases; buying back the Company's Shares is one of the options for effective management of the Company's capital which they keep under review. It is envisaged that purchases would only be made after considering the effect upon earnings per share and the benefits for shareholders generally.

There were no options outstanding as at the date of this Circular.